BioCentury | Dec 7, 2009
Clinical News

Nodlin: Phase I start

...oral Nodlin in up to 26 healthy volunteers. Shanghai Biolaxy is a subsidiary of NOD Pharmaceuticals. NOD Pharmaceuticals Inc....
BioCentury | Feb 12, 2007
Finance

Early exits on China plays

...and Schering-Plough Corp. (SGP, Kenilworth, N.J.). Finally, BioVeda led a $5.5 million B round for NOD Pharmaceuticals Inc....
Items per page:
1 - 2 of 2
BioCentury | Dec 7, 2009
Clinical News

Nodlin: Phase I start

...oral Nodlin in up to 26 healthy volunteers. Shanghai Biolaxy is a subsidiary of NOD Pharmaceuticals. NOD Pharmaceuticals Inc....
BioCentury | Feb 12, 2007
Finance

Early exits on China plays

...and Schering-Plough Corp. (SGP, Kenilworth, N.J.). Finally, BioVeda led a $5.5 million B round for NOD Pharmaceuticals Inc....
Items per page:
1 - 2 of 2